Effects of yoga interventions on Anti-Müllerian hormone, androgen levels, and metabolic parameters in women with polycystic ovary syndrome: a systematic review
Abstract
INTRODUCTION: Polycystic Ovary Syndrome is among the most prevalent endocrine disorders in women. Yoga has been suggested to affect hormonal and metabolic pathways, with implications for PCOS. To systematically review the effect of yoga on Anti-Müllerian hormone (AMH), androgen level, and metabolic parameters in women with PCOS. METHODS: The search was carried out in Scopus, Embase, PubMed, Web of Science, Cochrane Trials, and Clinical Trials to identify randomized controlled trials (RCTs). Females with confirmed diagnoses (Rotterdam criteria), undergone yoga intervention were included to explore its effects on AMH, androgen levels, and metabolic parameters. The Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) was used to assess the risk of bias. Due to the limited number of included studies and data heterogeneity, a meta-analysis was not performed; However, descriptive summaries of included studies are presented. RESULTS: Five publications were included; however, three were identified as linked reports from a single clinical trial. Consequently, the review represents data from 258 unique participants. Only one reported result for AMH level with a mean difference and (95% CI) of changes of -2.03 ng/mL (-4.08 to 0.02), testosterone level, -8.61 ng/dL (-21.80 to 4.58), LH level -7.10 mIU/mL (-12.26 to -1.93), FSH 0.08 mIU/mL (-1.52 to 1.36). Two studies showed a mean difference and (95% CI) of changes for FBG level -4.50 mg/dL (-6.61 to -2.39) and -4.90 mg/dL…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 258 participants or records.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.